ASCO 2019: Study examined the rates of non-relapse mortality in patients who receive treatment with CAR T therapies.
Home / Resource Library / Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS